Folia Parasitologica 57[2] 129-135 (2010) | DOI: 10.14411/fp.2010.016

The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients

Dunja Hinze-Selch1, Walter Däubener2, Sükran Erdag1, Sibylle Wilms1
1 The Centre for Integrative Psychiatry, Department of Psychiatry and Psychotherapy at the Christian Albrecht University, Niemannsweg 147, D-24105 Kiel, Germany
2 Institute for Medical Microbiology and Hospital Hygiene, Heinrich Heine University, Universitätsstrasse 1, D-40225 Düsseldorf, Germany

Individuals serologically positive for the chronic infection with the parasite Toxoplasma gondii (TG) display certain personality traits differently from uninfected individuals. Experimental data in mice demonstrate that TG infection modulates behaviour. However, psychiatric patients with a personality disorder have not yet been investigated systematically. In our sample containing 896 psychiatric inpatients with the primary diagnoses of schizophrenia, major depression, schizoaffective or bipolar disorder and 214 psychiatrically unaffected controls (same geographic region, sampled during same time period) we analysed for effects of the additional diagnosis of a personality disorder in the patients. Psychiatrically, a patient can meet the criteria of a personality disorder additionally to any of the mentioned primary diagnoses. We applied logistic regression and cross-table statistics, separated groups by the presence/absence of a personality disorder (ICD-10) and adjusted for age between groups. We found that among all patients the additional diagnosis of a personality disorder was significantly associated with TG infection. Furthermore, only in the patients with an additional personality disorder medium titre responses (1:16-1:64) were associated with chronic course and high C-reactive protein (CRP) levels whereas high titre response (>1:64) was associated with a more acute recurrent clinical course. In the older individuals only there was a preponderance of medium titre responses (1:16-1:64) among the patients with personality disorder compared to those without and controls. We conclude that TG infection and the host's response to it make a difference for the diagnosis of a personality disorder. Our data support that TG infection can modulate human behaviour and personality traits.

Keywords: Toxoplasma gondii, personality disorder, major depression, schizophrenia, serology

Received: January 11, 2010; Accepted: April 30, 2010; Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Hinze-Selch, D., Däubener, W., Erdag, S., & Wilms, S. (2010). The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitologica57(2), 129-135. doi: 10.14411/fp.2010.016
Download citation

References

  1. APA, American Psychiatric A ssociation 1994: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. APA, Washington D.C
  2. Bell M.A., Deater-Deckard K. 2007: Biological systems and the development of self-regulation: integrating behavior, genetics, and pathophysiology. J. Dev. Behav. Pediatr. 28: 409-420 Go to original source... Go to PubMed...
  3. Booij L., Van der D oes A.J., Riedel W.J. 2003: Monoamine depletion in psychiatric and healthy populations: review. Mol. Psychiat. 8: 951-973 Go to original source... Go to PubMed...
  4. Carruthers V.B., Blackman M.J. 2005: A new release on life: emerging concepts in proteolysis and parasite invasion. Mol. Microbiol. 55: 1617-1630 Go to original source... Go to PubMed...
  5. Cervenka S., Gustavsson J.P., Halldin C., Farde L. 2010: Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability. NeuroImage 50: 323-328 Go to original source... Go to PubMed...
  6. Daeubener W., Hadding U. 1997: Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system. Med. Microbiol. Immunol. (Berl.) 185: 195-206 Go to original source... Go to PubMed...
  7. Daeubener W., Spors B., Hucke C., Ruediger A., Stins M., Kim K.S., Schroten H. 2001: Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect. Immun. 69: 6527-6531 Go to original source... Go to PubMed...
  8. DeYoung C.G., Peterson J.B., Seguin J.R., Mejia J.M., Pihl R.O., Beitchman J.H., Jain U., Tremblay R.E., Kennedy J.L., Palmour R.M. 2006: The dopamine D4 receptor gene and moderation of the association between externalizing behavior and IQ. Arch. Gen. Psychiat. 63: 1410-1416 Go to original source... Go to PubMed...
  9. Fekadu A., Shibre T., Cleare A.J. 2010: Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms. Folia Parasitol. 57: 105-113 Go to original source... Go to PubMed...
  10. Filisetti D., Candolfi E. 2004: Immune response to Toxoplasma gondii. Ann. Ist. Super. Sanita 40: 71-80 Go to PubMed...
  11. Fischer H.G., Nitzgen B., Reichmann G., Gross U., Hadding U. 1997: Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol. Res. 83: 637-641 Go to original source... Go to PubMed...
  12. Flegr J., Hrdy I. 1994: Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 41: 122-126 Go to PubMed...
  13. Flegr J., Kodym P., Tolarova V. 2000: Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol. Psychol. 53: 57-68 Go to original source... Go to PubMed...
  14. Fujigaki S., Saito K., Takemura M., Maekawa N., Yamada Y. Wada H., Seishima M. 2002: L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect. Immun. 70: 779-786 Go to original source... Go to PubMed...
  15. Fujigaki S., Takemura M., Hamakawa H., Seishima M., Saito K. 2003: The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues. Adv. Exp. Med. Biol. 527: 97-103. Go to original source... Go to PubMed...
  16. Gaskell E.A., Smith J.E., Pinney J.W., Westhead D.R., Mc Co nkey G.A. 2009: A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS ONE 4: e4801 Go to original source... Go to PubMed...
  17. Halonen S.K., Lyman W.D., Chiu F.C. 1996: Growth and development of Toxoplasma gondii in human neurons and astrocytes. J. Neuropathol. Exp. Neurol. 55: 1150-1156 Go to original source... Go to PubMed...
  18. Henriquez S.A., Brett R., Alexander J., Pratt J., Roberts C.W. 2009: Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16: 122-133 Go to PubMed...
  19. Hiller W., Zaudig M., Mombour W. 1995: Internationale Diagnosen Checklisten fuer ICD-10 und DSM-IV. Verlag Hans Huber, Bern, Goettingen, Toronto, Seattle, 1. Ed., 127 pp
  20. Hinze -Selch D., Daeubener W., Eggert L., Erdag S., Stolten berg R., Wilms S. 2007: A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: Beyond seroprevalence. Schiz. Bull. 33: 782-788 Go to original source... Go to PubMed...
  21. Hoff E.F., Carruthers V.B. 2002: Is Toxoplasma egress the first step in invasion? Trends Parasitol. 18: 251-255 Go to original source... Go to PubMed...
  22. James W.H. 2010: Potential solutions to problems posed by the offspring sex ratios of people with parasitic and viral infections. Folia Parasitol. 57: 114-120 Go to original source... Go to PubMed...
  23. Kannan G., Moldovan K., Xiao J.-C., Yolken R.H., Jones Brando L., Pletnikov M.V. 2010: Toxoplasma gondii straindependent effects on mouse behaviour. Folia Parasitol. 57: 151-155 Go to original source... Go to PubMed...
  24. Kolbekova P., Kourbatova E., Novotna M., Kodym P., Flegr J. 2007: New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin. Microbiol. Infect. 13: 1012-1017 Go to original source... Go to PubMed...
  25. Leyton M., Ghadirian A.M., Young S.N., Palmour R.M., Bli er P., Helmers K.F., Benkelfat C. 2000: Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. J. Psychopharmacol. 14: 284-287 Go to original source... Go to PubMed...
  26. Lindova J., Kubena A.A., Sturcova H., Krivohlava R., Novotna M., Rubesova A., Havlicek J., Kodym P., Flegr J. 2010: Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol. 57: 136-142 Go to original source... Go to PubMed...
  27. Lindova J., Novotna M., Havlicek J., Jozifkova E., Skallova A., Kolbekova P., Hodny Z., Kodym P., Flegr J. 2006: Gender differences in behavioural changes induced by latent toxoplasmosis. Int. J. Parasitol. 36: 1485-1492 Go to original source... Go to PubMed...
  28. Luder C.G., Giraldo -Velasquez M., Sendtner M., Gross U. 1999: Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp. Parasitol. 93: 23-32 Go to original source... Go to PubMed...
  29. Miller C.L., Llenos I.C., Dulay J.R., Barillo M.M., Yolken R.H., Weis S. 2004: Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol. Dis. 15: 618-629 Go to original source... Go to PubMed...
  30. Moreno F.A., Heninger G.R., Mc Gahuey C.A., Delgado P.L. 2000: Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes. Biol. Psychiat. 48: 327-329 Go to original source... Go to PubMed...
  31. New A.S. G oodman M., Triebwasser J., Siever L.J. 2008: Recent advances in the biological study of personality disorders. Psychiatr. Clin. North Am. 31: 441-461 Go to original source... Go to PubMed...
  32. Oberdorfer C., Adams O., MacKenzie C.R., De Groot C.J., Daeubener W. 2003: Role of IDO activation in anti-microbial defense in human native astrocytes. Adv. Exp. Med. Biol. 527: 15-26 Go to original source... Go to PubMed...
  33. Perlman S.B., Morris J.P., Vander Wyk B.C., Green S.R., Doyle J.L., Pelphrey K.A. 2009: Individual differences in personality predict how people look at faces. PLoS ONE 22: e5952 Go to original source... Go to PubMed...
  34. Skallova A., Novotna M., Kolbekova P., Gasova Z., Vesely V., Sechovska M., Flegr J. 2005: Decreased level of novelty seeking in blood donors infected with Toxoplasma. Neuroendocrinol. Lett. 26: 480-486 Go to PubMed...
  35. Skallova A., Kodym P., Frynta D., Flegr J. 2006: The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 133: 525-535 Go to original source... Go to PubMed...
  36. Strueber D., Lueck M., Roth G. 2008: Sex, aggression and impulse control: an integrative account. Neurocase 14: 93-121 Go to original source... Go to PubMed...
  37. Tenter A.M., Heckeroth A.R., Weiss L.M. 2000: Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30: 1217-1258 Go to original source... Go to PubMed...
  38. Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. 2007: Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schiz. Bull. 33: 729-736 Go to original source... Go to PubMed...
  39. Vyas A., Sapolsky R. 2010: Manipulation of host behaviour by Toxoplasma gondii: what is the minimum a proposed proximate mechanism should explain? Folia Parasitol. 57: 88- 94 Go to original source... Go to PubMed...
  40. WHO 1993: Mental and behavioural disorders. Diagnostic criteria for research. In: Tenth Revision of the International Classification of Diseases, F-diagnoses
  41. Webster J.P., Mc Conkey G.A. 2010: Toxoplasma gondii-altered host behaviour: clues as to mechanism of action. Folia Parasitologica 57: 95-104 Go to original source... Go to PubMed...
  42. Widner B., Laich A., Sperner-Unterweger B., Ledochowski M., Fuchs D. 2002: Neopterin production, tryptophan degradation, and mental depression - what is the link? Brain Behav. Immun. 16: 590-595 Go to original source... Go to PubMed...